These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 9111502
1. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. Håkansson L, Heinrich C, Rak S, Venge P. J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502 [Abstract] [Full Text] [Related]
2. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. Pfaar O, Bachert C, Kuna P, Panzner P, Džupinová M, Klimek L, van Nimwegen MJ, Boot JD, Yu D, Opstelten DJE, de Kam PJ. J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538 [Abstract] [Full Text] [Related]
3. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U. J Allergy Clin Immunol; 2002 Feb; 109(2):251-6. PubMed ID: 11842293 [Abstract] [Full Text] [Related]
4. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Cirla AM, Cirla PE, Parmiani S, Pecora S. Allergol Immunopathol (Madr); 2003 Feb; 31(1):31-43. PubMed ID: 12573207 [Abstract] [Full Text] [Related]
5. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. Rak S, Håkanson L, Venge P. J Allergy Clin Immunol; 1990 Nov; 86(5):706-13. PubMed ID: 2229837 [Abstract] [Full Text] [Related]
6. The effect of immunotherapy on T-cell subsets in peripheral blood and bronchoalveolar lavage fluid in pollen-allergic patients. Rak S, Hallden G, Sörenson S, Margari V, Scheynius A. Allergy; 1993 Aug; 48(6):460-5. PubMed ID: 8238803 [Abstract] [Full Text] [Related]
7. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. Rak S, Löwhagen O, Venge P. J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):470-80. PubMed ID: 3170995 [Abstract] [Full Text] [Related]
8. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Rak S, Heinrich C, Scheynius A. Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810 [Abstract] [Full Text] [Related]
15. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Möller C, Dreborg S, Lanner A, Björkstén B. Allergy; 1986 May; 41(4):271-9. PubMed ID: 3530030 [Abstract] [Full Text] [Related]